Psychotropic drug prescribing in child and adolescent learning disability psychiatry
Psychotropic drug prescribing in child and adolescent learning disability psychiatry
复制标题
DOI：
10.1177/0269881106075642
复制
发表时间：
2007-07-01
影响因子：
4.1
通讯作者：
Bramble, David
中科院分区：
文献类型：
--
作者：
Bramble, David
这项邮寄问卷调查研究的处方做法的一组资深的英国精神科医生谁有责任的儿童和青少年学习障碍（精神发育迟滞）。该研究显示，所有接受调查的临床医生（n = 16）均开具精神药物处方;精神兴奋剂和主要镇静剂是最常开具的类别，哌甲酯、利培酮、褪黑素、丙戊酸钠和卡马西平分别是最常使用的特定药物。大多数患者接受单药治疗。许多（14/16）临床医生报告了与全科医生共同护理处方安排的困难。该研究的结论是，精神药理学是一个既定的一部分，学习障碍儿童的精神病管理，但承认需要制定临床治理标准，这方面的做法。
This postal questionnaire study investigated the prescribing practices of a group of senior British psychiatrists who have responsibilities for children and adolescents with Learning disabilities (mental retardation). The study revealed that all of the clinicians surveyed (n = 16) were prescribing psychotropic medication; psychostimulants and major tranquillizers represented the most frequently prescribed classes and, respectively, methylphenidate, risperidone, melatonin, sodium valproate and carbamazepine were the most frequently employed specific agents. Most patients were receiving monotherapy. Many (14/16) clinicians reported difficulties in shared-care prescribing arrangements with General Practitioners. The study concludes that psychopharmacology is an established part of the psychiatric management of Learning disabled children but acknowledges the need for the elaboration of clinical governance standards to this area of practice.